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Methods
We studied all individuals born between 1960 and 1998 and diagnosed with ADHD in Sweden (n= 38,752). We obtained data for prescription of ADHD medication, diagnosis of depression and other psychiatric disorders, and socio-demographic factors from population-based registers. The association between ADHD medication and depression was estimated with Cox proportional hazards regression.
Results ADHD medication was associated with a reduced long-term risk for depression (i.e., three years later), after adjustment for a number of socio-demographic and clinical confounders (HR=0.58, 95% CI: 0.51-0.67). The risk was lower for longer duration of ADHD medication. ADHD medication was also associated with reduced rates of concurrent depression; within-individual analysis suggested that occurrence of depression was 20% less common during periods when patients received ADHD medication compared with periods when they did not (HR=0.80, 95% CI: 0.70-0.92).
Conclusions
Our study suggests that ADHD medication does not increase the risk of later depression; rather, medication was associated with a reduced risk for subsequent and concurrent depression.
